000 01685 a2200505 4500
005 20250517031047.0
264 0 _c20160315
008 201603s 0 0 eng d
022 _a1549-490X
024 7 _a10.1634/theoncologist.2014-0439
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJia, Ru
245 0 0 _aPhase II Study of Recombinant Antitumor and Antivirus Protein Injection Compared With Placebo in Metastatic Colorectal Cancer After Failure of Standard Treatment.
_h[electronic resource]
260 _bThe oncologist
_cJun 2015
300 _a619-20 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aColorectal Neoplasms
_xdrug therapy
650 0 4 _aDrug-Related Side Effects and Adverse Reactions
_xpathology
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInterferons
_xadministration & dosage
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Metastasis
650 0 4 _aPalliative Care
650 0 4 _aRecombinant Proteins
_xadministration & dosage
650 0 4 _aTreatment Failure
700 1 _aWang, Yan
700 1 _aMao, Xiao-Yang
700 1 _aLi, Shan-Shan
700 1 _aXu, Nong
700 1 _aXiong, Jian-Ping
700 1 _aShen, Lin
700 1 _aBai, Li
700 1 _aLiu, Wei
700 1 _aLiu, Lie-Jun
700 1 _aGe, Fei-Jiao
700 1 _aChen, Yu-Ling
700 1 _aLin, Li
700 1 _aXu, Jian-Ming
773 0 _tThe oncologist
_gvol. 20
_gno. 6
_gp. 619-20
856 4 0 _uhttps://doi.org/10.1634/theoncologist.2014-0439
_zAvailable from publisher's website
999 _c24854974
_d24854974